Botanical species · safety record

Daemonorops draco

The EFSA Compendium of Botanicals holds 3 constituent measurements for Daemonorops draco. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Daemonorops draco (Willd.) Blume

3Constituent measurements
0Safety records
3Cited sources
50Licensed products (Canada)

Also recorded as

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 50 licensed products naming Daemonorops draco as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

  • Dry

Source material stated

  • Balsam
  • Fruit
  • Fruit Resin
  • Prepared Resin
  • Resin
  • Sap resin
  • Whole plant

What the records describe

Constituents measured

  • Coumarins1
  • Dracorhodin1
  • Steroidal saponins1

Plant parts

  • Unspecified2
  • Live plants1

Preparations

  • Solvent extraction2

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
CoumarinsLive plantsSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
DracorhodinUnspecifiedSolvent extractionUnspecifiedNo resolvable identifier
Steroidal saponinsUnspecifiedUnspecifiedNo resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Liu, Fang., Dai, Rongji., Deng, Yulin., Meng, Weiwei., Jin, Xiaoyun. Research progress on the chemical constituents of Daemonorops draco. Zhongguo yaofang, 2010, p. 1437-1439.
  2. Mazzio, Elizabeth A., Soliman, Karam F. A. In vitro screening for the tumoricidal properties of international medicinal herbs. Phytotherapy research, 2009, p. 385-398.
  3. Hao, Qian., Saito, Yoshinori., Matsuo, Yosuke., Li, Hai-Zhou., Takashi, Tanaka. Three new flavans in dragon's blood from Daemonorops draco. Natural product research, 2015, vol. 29, no. 15, p. 1419-1425. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue